ORIENT BIO Inc. (KRX:002630)
South Korea · Delayed Price · Currency is KRW 840.00
-33.00 (-3.78%)
Sep 1, 2026, 3:30 PM KST
ORIENT BIO Market Cap
ORIENT BIO has a market cap or net worth of 51.75 billion as of September 1, 2026. Its market cap has decreased by -26.14% in one year.
Market Cap
51.75B
Enterprise Value
n/a
Revenue
59.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
840.00
ChartMarket Cap Chart
Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 51.75B, an increase of 65.88%. That is a compound annual growth rate of 1.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 51.75B | -27.37% |
| Dec 30, 2025 | 71.26B | -61.15% |
| Dec 30, 2024 | 183.42B | 154.86% |
| Dec 28, 2023 | 71.97B | -0.98% |
| Dec 29, 2022 | 72.68B | -49.75% |
| Dec 30, 2021 | 144.65B | -3.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genexine | 124.39B |
| MedPacto | 93.91B |
| Vaxcell-Bio Therapeutics | 93.03B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 77.28B |
| Amicogen | 68.34B |
| ENCell | 66.51B |
| GeneOne Life Science | 48.42B |